chr6-31270541-G-C

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_002117.6(HLA-C):​c.620-56C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0 ( 0 hom., cov: 2)
Exomes 𝑓: 0.0000043 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

HLA-C
NM_002117.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.25

Publications

27 publications found
Variant links:
Genes affected
HLA-C (HGNC:4933): (major histocompatibility complex, class I, C) HLA-C belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domain, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. About 6000 HLA-C alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002117.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-C
NM_002117.6
MANE Select
c.620-56C>G
intron
N/ANP_002108.4

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-C
ENST00000376228.10
TSL:6 MANE Select
c.620-56C>G
intron
N/AENSP00000365402.5
HLA-C
ENST00000383329.7
TSL:6
c.620-56C>G
intron
N/AENSP00000372819.3
HLA-C
ENST00000415537.1
TSL:6
c.617-56C>G
intron
N/AENSP00000400410.1

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
56076
Hom.:
0
Cov.:
2
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000428
AC:
3
AN:
700142
Hom.:
0
Cov.:
10
AF XY:
0.00000578
AC XY:
2
AN XY:
345760
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
11546
American (AMR)
AF:
0.00
AC:
0
AN:
17288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
6020
East Asian (EAS)
AF:
0.0000906
AC:
1
AN:
11040
South Asian (SAS)
AF:
0.00
AC:
0
AN:
33294
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
25432
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1870
European-Non Finnish (NFE)
AF:
0.00000177
AC:
1
AN:
565896
Other (OTH)
AF:
0.0000360
AC:
1
AN:
27756
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
56076
Hom.:
0
Cov.:
2
AF XY:
0.00
AC XY:
0
AN XY:
26620
African (AFR)
AF:
0.00
AC:
0
AN:
10906
American (AMR)
AF:
0.00
AC:
0
AN:
4944
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
750
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1412
South Asian (SAS)
AF:
0.00
AC:
0
AN:
1516
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4040
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
98
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
31314
Other (OTH)
AF:
0.00
AC:
0
AN:
658
Alfa
AF:
0.00
Hom.:
1224

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
3.9
DANN
Benign
0.51
PhyloP100
-1.3

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9264638; hg19: chr6-31238318; API